A year after the Ice Bucket Challenge swept across the nation, bringing in millions of dollars to support research for amyotrophic lateral sclerosis, the ALS Association is putting the first of that cash toward clinical trials.
On 14 July, Cytokinetics announced that it is initiating a Phase III clinical trial in patients with ALS using a...
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on Scrip for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?
